These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18029833)

  • 1. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
    Grigsby PW; Siegel BA; Dehdashti F; Rader J; Zoberi I
    J Clin Oncol; 2004 Jun; 22(11):2167-71. PubMed ID: 15169804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
    Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
    Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
    J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of posttherapy
    Liu FY; Su TP; Wang CC; Chao A; Chou HH; Chang YC; Yen TC; Lai CH
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1197-1204. PubMed ID: 29470614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
    Kunos C; Radivoyevitch T; Abdul-Karim FW; Faulhaber P
    Int J Gynecol Cancer; 2011 Aug; 21(6):1117-23. PubMed ID: 21792015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
    Siva S; Herschtal A; Thomas JM; Bernshaw DM; Gill S; Hicks RJ; Narayan K
    Cancer; 2011 Sep; 117(17):3981-8. PubMed ID: 21365626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
    Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
    Yen TC; See LC; Chang TC; Huang KG; Ng KK; Tang SG; Chang YC; Hsueh S; Tsai CS; Hong JH; Lin CT; Chao A; Ma SY; Lin WJ; Fu YK; Fan CC; Lai CH
    J Nucl Med; 2004 Oct; 45(10):1632-9. PubMed ID: 15471826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.
    Siva S; Deb S; Young RJ; Hicks RJ; Callahan J; Bressel M; Mileshkin L; Rischin D; Bernshaw D; Narayan K
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1825-32. PubMed ID: 26173619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.
    Xue F; Lin LL; Dehdashti F; Miller TR; Siegel BA; Grigsby PW
    Gynecol Oncol; 2006 Apr; 101(1):147-51. PubMed ID: 16263155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
    Brooks RA; Rader JS; Dehdashti F; Mutch DG; Powell MA; Thaker PH; Siegel BA; Grigsby PW
    Gynecol Oncol; 2009 Jan; 112(1):104-9. PubMed ID: 18929403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
    Chung HH; Kim SK; Kim TH; Lee S; Kang KW; Kim JY; Park SY
    Gynecol Oncol; 2006 Oct; 103(1):165-70. PubMed ID: 16574205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
    Grigsby PW; Siegel BA; Dehdashti F; Mutch DG
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):907-13. PubMed ID: 12605968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
    Kim YJ; Han S; Kim YS; Nam JH
    J Gynecol Oncol; 2019 Sep; 30(5):e66. PubMed ID: 31328452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutic S; Mutch DG; Powell MA; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1085-91. PubMed ID: 19880262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral metabolic heterogeneity of cervical cancer.
    Kidd EA; Grigsby PW
    Clin Cancer Res; 2008 Aug; 14(16):5236-41. PubMed ID: 18698042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT imaging to guide cervical cancer therapy.
    Grigsby PW
    Future Oncol; 2009 Sep; 5(7):953-8. PubMed ID: 19792965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.